Bilsborough W, Keen H, Taylor A, O'Driscoll GJ, Arnolda L, Green DJ
Antibodies, Monoclonal; Antirheumatic Agents; Arthritis, Rheumatoid; Endothelium, Vascular; Immunoglobulin G; Receptors, Tumor Necrosis Factor; Tumor Necrosis Factor-alpha
Adult; Brachial Artery; Etanercept; Female; Humans; Infliximab; Male; Middle Aged; Regional Blood Flow; Vasodilation
Bilsborough W, Keen H, Taylor A, O'Driscoll GJ, Arnolda L, Green DJ. Anti-tumour necrosis factor-alpha therapy over conventional therapy improves endothelial function in adults with rheumatoid arthritis. Rheumatol Int. 2006 Oct; 26(12):1125-31.
Anti-tumour necrosis factor-alpha therapy over conventional therapy improves endothelial function in adults with rheumatoid arthritis.